查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1447130

到 2030 年 L-麦角硫因市场预测：按类型、原材料、型态、分销管道、应用和地区进行的全球分析

L-ergothioneine Market Forecasts to 2030 - Global Analysis By Type (Fermentation-based Production, Chemical Synthesis and Biosynthesis), By Source (Mushrooms, Algae and Bacteria), Form, Distribution Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年 L-麦角硫因的全球市场规模为 3,950 万美元，预计在预测期内将以 34.4% 的复合年增长率增长，并在 2030 年达到 3.128 亿美元。

L-麦角硫因是一种天然存在的胺基酸衍生物，具有强烈的抗氧化特性。它由某些真菌和细菌合成，在各种食品中含有微量。 L-麦角硫因可作为有害自由基的清除剂，保护细胞免受氧化损伤，并可能具有发炎和抗衰老等健康益处。

据美国国家癌症美国称，蘑菇的抗氧化特性可能有助于降低乳癌、摄护腺癌和肺癌的风险。

慢性病增加

慢性病的增加是 L-麦角硫因市场的驱动因素。慢性疾病的特征是氧化压力和发炎，导致组织损伤和功能障碍。 L-麦角硫因具有很强的抗氧化和发炎特性，已显示出减轻氧化损伤和发炎的潜力，从而为慢性病的预防和管理提供治疗益处。这增加了对 L-麦角硫因作为营养补充和药物配方中的功能成分的需求。

生产成本高

涉及发酵和化学合成的复杂且专业的製造流程需要精密的设备和熟练的劳动力，导致製造成本不断上升。此外，L-麦角硫因的天然来源有限，进一步加剧了生产成本。这些高成本导致 L-麦角硫因产品价格高昂，并可能阻碍市场成长和普及。

合成L-麦角硫因的开发

与天然来源萃取相比，合成生产方法具有成本效益、扩充性和品管等优点。这可以满足药品、化妆品、营养补充等各行业对L-麦角硫因日益增长的需求。此外，合成生产允许客製化和配方弹性，允许创建新的应用并增加 L-麦角硫因在市场上的可用性。

存在仿冒品和劣质 L-麦角硫因产品

仿冒品和劣质 L-麦角硫因产品的存在对市场构成威胁。这些产品可能缺乏功效、纯度和安全性，并对消费者构成潜在的健康风险。此外，它还削弱了消费者对 L-麦角硫因和整个产业的信心。此类产品的氾滥也损害了合法製造商和分销商的声誉，阻碍了市场成长。

COVID-19 的影响：

COVID-19 大流行对 L-麦角硫因市场产生了重大影响。在大流行期间，人们对健康和免疫力的兴趣增加，导致人们对 L-麦角硫因等抗氧化剂的兴趣增加。然而，供应链和製造业务的中断影响了生产和分销，导致供应和价格波动。儘管面临挑战，疫情凸显了 L-麦角硫因的潜在健康益处，并推动了对该成分的需求。

预计粉末细分市场在预测期内将是最大的

在L-麦角硫因市场中，由于各种因素，预计粉末部分在预测期内将成为最大的部分。粉状 L-麦角硫因具有多种配方和用途，可用于多种行业，包括药品、化妆品和食品。此外，製造商更喜欢粉末状，因为它们更容易处理、储存和掺入配方中。此外，粉末状L-麦角硫因可以轻鬆标准化并配製成各种产品，使其在市场上具有竞争优势。

预计製药业在预测期内复合年增长率最高

在L-麦角硫因市场中，製药领域预计在预测期内将呈现最高成长率。这一增长归因于专注于探索 L-麦角硫因在治疗各种疾病方面的治疗潜力的研发活动的增加。此外，慢性病和与老龄化相关的疾病盛行率不断上升，刺激了对含有 L-麦角硫因的创新药物配方的需求，从而推动了製药业的成长。

比最大的地区

由于其发达的医疗保健基础设施、消费者对健康和保健的意识不断增强以及製药和化妆品行业的主要企业的存在，预计北美将主导 L-麦角硫因市场。此外，积极的研发活动，加上对含有L-麦角硫因的营养补充和护肤品的需求不断增长，使得北美在L-麦角硫因市场上占据了最大的市场占有率。

复合年增长率最高的地区：

由于人口成长、可支配收入增加以及人们对健康和保健意识的提高，预计亚太地区 L-麦角硫因市场将快速成长。此外，中国、日本和印度等国家的製药、化妆品和营养补充产业不断扩大，为L-麦角硫因製造商创造了庞大的商机。此外，支持研发活动的有利政府倡议进一步促进了该地区市场的快速成长潜力。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球 L-麦角硫因市场：依类型

  • 发酵生产
  • 化学合成
  • 生物合成

第六章全球 L-麦角硫因市场：依原料分类

  • 菇
    • 药用菇
    • 食用菌
  • 藻类
  • 细菌

第七章全球 L-麦角硫因市场：依型态

  • 粉末
  • 液体
  • 胶囊
  • 其他型态

第八章全球 L-麦角硫因市场：按分销管道

  • 直销
  • 代理销售
  • 网路零售
  • 专卖店

第九章全球 L-麦角硫因市场：依应用分类

  • 药品
  • 个人护理和化妆品
  • 食品与饮品
  • 其他用途

第十章全球 L-麦角硫因市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司简介

  • Alfa Aesar
  • BOC Sciences
  • Cayman Chemical
  • ChemFaces
  • Chemieliva Pharmaceutical Co., Ltd.
  • Chemwill Asia Co., Ltd.
  • Evonik Industries AG
  • Gea Group AG
  • Gold Biotechnology, Inc.
  • Hangzhou J&H Chemical Co., Ltd.
  • Hangzhou Lingrui Chemical Co., Ltd.
  • Hefei TNJ Chemical Industry Co., Ltd.
  • Henan Tianfu Chemical Co., Ltd.
  • Kanto Chemical Co., Inc.
  • Merck KGaA
  • Santa Cruz Biotechnology, Inc.
  • Shanghai Haoyuan Chemexpress Co., Ltd.
  • Suzhou Health Chemicals Co., Ltd.
  • Zhonglan Industry Co., Ltd.
Product Code: SMRC25391

According to Stratistics MRC, the Global L-ergothioneine Market is accounted for $39.5 million in 2023 and is expected to reach $312.8 million by 2030 growing at a CAGR of 34.4% during the forecast period. L-ergothioneine is a naturally occurring amino acid derivative with potent antioxidant properties. It is synthesized by certain fungi and bacteria and is found in trace amounts in various foods. L-ergothioneine acts as a scavenger of harmful free radicals, protecting cells from oxidative damage and potentially offering health benefits, including anti-inflammatory and anti-aging effects.

According to the National Cancer Institute, the antioxidant property of mushrooms may help to reduce the risk of breast, prostate, lung, and other cancers.

Market Dynamics:

Driver:

Increasing prevalence of chronic diseases

The increasing prevalence of chronic diseases serves as a driver in the L-ergothioneine market. Chronic diseases are characterized by oxidative stress and inflammation, leading to tissue damage and dysfunction. L-ergothioneine, with its potent antioxidant and anti-inflammatory properties, has shown potential for mitigating oxidative damage and inflammation, thereby offering therapeutic benefits in the prevention and management of chronic diseases. This drives the demand for L-ergothioneine as a functional ingredient in dietary supplements and pharmaceutical formulations.

Restraint:

High production costs

The complex and specialized production process, which involves fermentation or chemical synthesis, requires sophisticated equipment and skilled labor, contributing to elevated manufacturing expenses. Additionally, the limited natural sources of L-ergothioneine further exacerbate production costs. These high expenses may result in higher prices for L-ergothioneine products, potentially hindering market growth and adoption.

Opportunity:

Development of synthetic L-ergothioneine

Synthetic production methods can offer advantages such as cost-effectiveness, scalability, and quality control compared to extraction from natural sources. This can meet the increasing demand for L-ergothioneine in various industries, including pharmaceuticals, cosmetics, and dietary supplements. Moreover, synthetic production allows for customization and formulation flexibility, enabling the creation of new applications and enhancing the accessibility of L-ergothioneine on the market.

Threat:

Presence of counterfeit or low-quality L-ergothioneine products

The presence of counterfeit or low-quality L-ergothioneine products poses a threat to the market. These products may lack efficacy, purity, and safety, leading to potential health risks for consumers. Furthermore, they undermine consumer trust in L-ergothioneine and the industry as a whole. The proliferation of such products can also tarnish the reputation of legitimate manufacturers and distributors, which hinders market growth.

Covid-19 Impact:

The COVID-19 pandemic had a significant impact on the L-ergothioneine market. The increased focus on health and immunity during the pandemic led to a growing interest in antioxidants like L-ergothioneine. However, disruptions in supply chains and manufacturing operations affected production and distribution, resulting in fluctuating availability and pricing. Despite the challenges, the pandemic highlighted the potential health benefits of L-ergothioneine, driving demand for the ingredient.

The powder segment is expected to be the largest during the forecast period

The powder segment is anticipated to be the largest during the forecast period in the L-ergothioneine market due to various factors. Powdered L-ergothioneine offers versatility in formulation and application across various industries, including pharmaceuticals, cosmetics, and dietary supplements. Additionally, powdered form facilitates easy handling, storage, and blending into formulations, making it preferred by manufacturers. Moreover, powdered L-ergothioneine can be easily standardized and formulated into different products, driving its dominance in the market.

The pharmaceuticals segment is expected to have the highest CAGR during the forecast period

The pharmaceuticals segment is projected to experience the highest growth rate during the forecast period in the L-ergothioneine market. This growth can be attributed to the increasing research and development activities focused on exploring the therapeutic potential of L-ergothioneine in treating various medical conditions. Additionally, the rising prevalence of chronic diseases and age-related disorders has fueled demand for innovative pharmaceutical formulations containing L-ergothioneine, driving its growth in the pharmaceuticals segment.

Region with largest share:

North America is expected to dominate the L-ergothioneine market due to the region's advanced healthcare infrastructure, increasing consumer awareness about health and wellness, and the presence of key players in the pharmaceutical and cosmetic industries. Additionally, robust research and development activities, coupled with a growing demand for dietary supplements and skincare products containing L-ergothioneine, further contribute to North America's anticipated largest market share in the L-ergothioneine market.

Region with highest CAGR:

The Asia-Pacific region is poised for rapid growth in the L-ergothioneine market due to the region's increasing population, rising disposable incomes, and growing awareness of health and wellness. Additionally, the expanding pharmaceutical, cosmetic, and dietary supplement industries in countries like China, Japan, and India present significant opportunities for L-ergothioneine manufacturers. Moreover, favorable government initiatives supporting research and development activities further contribute to the region's potential for rapid market growth.

Key players in the market

Some of the key players in L-ergothioneine market include Alfa Aesar, BOC Sciences, Cayman Chemical, ChemFaces, Chemieliva Pharmaceutical Co., Ltd., Chemwill Asia Co., Ltd., Evonik Industries AG, Gea Group AG, Gold Biotechnology, Inc., Hangzhou J&H Chemical Co., Ltd., Hangzhou Lingrui Chemical Co., Ltd., Hefei TNJ Chemical Industry Co., Ltd., Henan Tianfu Chemical Co., Ltd., Kanto Chemical Co., Inc., Merck KGaA, Santa Cruz Biotechnology, Inc., Shanghai Haoyuan Chemexpress Co., Ltd., Suzhou Health Chemicals Co., Ltd. and Zhonglan Industry Co., Ltd.

Key Developments:

In June 2022, BOC Sciences, a leading CRO in the pharmaceutical industry, demonstrates its comprehensive strength through innovative lysosome-targeting chimera (LYTAC) degradation technology solutions developed within the field of targeted protein degradation. LYTAC is a new technology that can degrade extracellular proteins and membrane-related proteins through the endosomal/lysosomal pathway.

In October 2021, Thermo Fisher Scientific recently announced consolidation of its product portfolio brands Acros Organics, Alfa Aesar and Maybridge transitioning to one unified brand, Thermo Scientific. This transition is a response to the customer's feedback to simplify the buying journey experience. The transition will be effective from mid- October 2021 and all products of Alfa Aesar(TM), Acros, Organics(TM) and Maybridge(TM) packed and labeled from mid-October 2021 onwards will be branded as Thermo Scientific(TM).

Types Covered:

  • Fermentation-based Production
  • Chemical Synthesis
  • Biosynthesis

Sources Covered:

  • Mushrooms
  • Algae
  • Bacteria

Forms Covered:

  • Powder
  • Liquid
  • Capsule
  • Other Forms

Distribution Channels Covered:

  • Direct Sales
  • Distributors
  • Online Retail
  • Specialty Stores

Applications Covered:

  • Pharmaceuticals
  • Personal Care & Cosmetics
  • Food & Beverages
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global L-ergothioneine Market, By Type

  • 5.1 Introduction
  • 5.2 Fermentation-based Production
  • 5.3 Chemical Synthesis
  • 5.4 Biosynthesis

6 Global L-ergothioneine Market, By Source

  • 6.1 Introduction
  • 6.2 Mushrooms
    • 6.2.1 Medicinal Mushrooms
    • 6.2.2 Edible Mushrooms
  • 6.3 Algae
  • 6.4 Bacteria

7 Global L-ergothioneine Market, By Form

  • 7.1 Introduction
  • 7.2 Powder
  • 7.3 Liquid
  • 7.4 Capsule
  • 7.5 Other Forms

8 Global L-ergothioneine Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Direct Sales
  • 8.3 Distributors
  • 8.4 Online Retail
  • 8.5 Specialty Stores

9 Global L-ergothioneine Market, By Application

  • 9.1 Introduction
  • 9.2 Pharmaceuticals
  • 9.3 Personal Care & Cosmetics
  • 9.4 Food & Beverages
  • 9.5 Other Applications

10 Global L-ergothioneine Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Alfa Aesar
  • 12.2 BOC Sciences
  • 12.3 Cayman Chemical
  • 12.4 ChemFaces
  • 12.5 Chemieliva Pharmaceutical Co., Ltd.
  • 12.6 Chemwill Asia Co., Ltd.
  • 12.7 Evonik Industries AG
  • 12.8 Gea Group AG
  • 12.9 Gold Biotechnology, Inc.
  • 12.10 Hangzhou J&H Chemical Co., Ltd.
  • 12.11 Hangzhou Lingrui Chemical Co., Ltd.
  • 12.12 Hefei TNJ Chemical Industry Co., Ltd.
  • 12.13 Henan Tianfu Chemical Co., Ltd.
  • 12.14 Kanto Chemical Co., Inc.
  • 12.15 Merck KGaA
  • 12.16 Santa Cruz Biotechnology, Inc.
  • 12.17 Shanghai Haoyuan Chemexpress Co., Ltd.
  • 12.18 Suzhou Health Chemicals Co., Ltd.
  • 12.19 Zhonglan Industry Co., Ltd.

List of Tables

  • Table 1 Global L-ergothioneine Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global L-ergothioneine Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global L-ergothioneine Market Outlook, By Fermentation-based Production (2021-2030) ($MN)
  • Table 4 Global L-ergothioneine Market Outlook, By Chemical Synthesis (2021-2030) ($MN)
  • Table 5 Global L-ergothioneine Market Outlook, By Biosynthesis (2021-2030) ($MN)
  • Table 6 Global L-ergothioneine Market Outlook, By Source (2021-2030) ($MN)
  • Table 7 Global L-ergothioneine Market Outlook, By Mushrooms (2021-2030) ($MN)
  • Table 8 Global L-ergothioneine Market Outlook, By Medicinal Mushrooms (2021-2030) ($MN)
  • Table 9 Global L-ergothioneine Market Outlook, By Edible Mushrooms (2021-2030) ($MN)
  • Table 10 Global L-ergothioneine Market Outlook, By Algae (2021-2030) ($MN)
  • Table 11 Global L-ergothioneine Market Outlook, By Bacteria (2021-2030) ($MN)
  • Table 12 Global L-ergothioneine Market Outlook, By Form (2021-2030) ($MN)
  • Table 13 Global L-ergothioneine Market Outlook, By Powder (2021-2030) ($MN)
  • Table 14 Global L-ergothioneine Market Outlook, By Liquid (2021-2030) ($MN)
  • Table 15 Global L-ergothioneine Market Outlook, By Capsule (2021-2030) ($MN)
  • Table 16 Global L-ergothioneine Market Outlook, By Other Forms (2021-2030) ($MN)
  • Table 17 Global L-ergothioneine Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 18 Global L-ergothioneine Market Outlook, By Direct Sales (2021-2030) ($MN)
  • Table 19 Global L-ergothioneine Market Outlook, By Distributors (2021-2030) ($MN)
  • Table 20 Global L-ergothioneine Market Outlook, By Online Retail (2021-2030) ($MN)
  • Table 21 Global L-ergothioneine Market Outlook, By Specialty Stores (2021-2030) ($MN)
  • Table 22 Global L-ergothioneine Market Outlook, By Application (2021-2030) ($MN)
  • Table 23 Global L-ergothioneine Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 24 Global L-ergothioneine Market Outlook, By Personal Care & Cosmetics (2021-2030) ($MN)
  • Table 25 Global L-ergothioneine Market Outlook, By Food & Beverages (2021-2030) ($MN)
  • Table 26 Global L-ergothioneine Market Outlook, By Other Applications (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.